97 related articles for article (PubMed ID: 24549567)
1. Type II cGMP‑dependent protein kinase inhibits RhoA activation in gastric cancer cells.
Wang Y; Chen Y; Li Y; Lan T; Qian H
Mol Med Rep; 2014 Apr; 9(4):1444-52. PubMed ID: 24549567
[TBL] [Abstract][Full Text] [Related]
2. The cross talk between protein kinase A- and RhoA-mediated signaling in cancer cells.
Chen Y; Wang Y; Yu H; Wang F; Xu W
Exp Biol Med (Maywood); 2005 Nov; 230(10):731-41. PubMed ID: 16246900
[TBL] [Abstract][Full Text] [Related]
3. Type II cGMP-dependent protein kinase directly inhibits HER2 activation of gastric cancer cells.
Zhu M; Yao X; Wu M; Qian H; Wu Y; Chen Y
Mol Med Rep; 2016 Feb; 13(2):1909-13. PubMed ID: 26676300
[TBL] [Abstract][Full Text] [Related]
4. Type II cGMP-dependent protein kinase inhibits EGF-induced MAPK/JNK signal transduction in breast cancer cells.
Lan T; Chen Y; Sang J; Wu Y; Wang Y; Jiang L; Tao Y
Oncol Rep; 2012 Jun; 27(6):2039-44. PubMed ID: 22427012
[TBL] [Abstract][Full Text] [Related]
5. Type II cGMP-dependent protein kinase inhibits ligand‑induced activation of EGFR in gastric cancer cells.
Jiang L; Chen Y; Li Y; Lan T; Wu M; Wang Y; Qian H
Mol Med Rep; 2014 Apr; 9(4):1405-9. PubMed ID: 24534906
[TBL] [Abstract][Full Text] [Related]
6. Type II cGMP‑dependent protein kinase inhibits EGF‑induced JAK/STAT signaling in gastric cancer cells.
Wu M; Wu Y; Lan T; Jiang L; Qian H; Chen Y
Mol Med Rep; 2016 Aug; 14(2):1849-56. PubMed ID: 27357186
[TBL] [Abstract][Full Text] [Related]
7. AKAPs competing peptide HT31 disrupts the inhibitory effect of PKA on RhoA activity.
Wang Y; Chen Y; Chen M; Xu W
Oncol Rep; 2006 Oct; 16(4):755-61. PubMed ID: 16969490
[TBL] [Abstract][Full Text] [Related]
8. cGMP-dependent protein kinase phosphorylates and inactivates RhoA.
Sawada N; Itoh H; Yamashita J; Doi K; Inoue M; Masatsugu K; Fukunaga Y; Sakaguchi S; Sone M; Yamahara K; Yurugi T; Nakao K
Biochem Biophys Res Commun; 2001 Jan; 280(3):798-805. PubMed ID: 11162591
[TBL] [Abstract][Full Text] [Related]
9. NET1-mediated RhoA activation facilitates lysophosphatidic acid-induced cell migration and invasion in gastric cancer.
Murray D; Horgan G; Macmathuna P; Doran P
Br J Cancer; 2008 Oct; 99(8):1322-9. PubMed ID: 18827818
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase A inhibits lysophosphatidic acid-induced migration of airway smooth muscle cells.
Hirakawa M; Karashima Y; Watanabe M; Kimura C; Ito Y; Oike M
J Pharmacol Exp Ther; 2007 Jun; 321(3):1102-8. PubMed ID: 17347321
[TBL] [Abstract][Full Text] [Related]
11. Type II, but not type I, cGMP-dependent protein kinase reverses bFGF-induced proliferation and migration of U251 human glioma cells.
Cao ZH; Tao Y; Sang JR; Gu YJ; Bian XJ; Chen YC
Mol Med Rep; 2013 Apr; 7(4):1229-34. PubMed ID: 23404188
[TBL] [Abstract][Full Text] [Related]
12. Type II cGMP-dependent protein kinase negatively regulates fibroblast growth factor signaling by phosphorylating Raf-1 at serine 43 in rat chondrosarcoma cells.
Kamemura N; Murakami S; Komatsu H; Sawanoi M; Miyamoto K; Ishidoh K; Kishimoto K; Tsuji A; Yuasa K
Biochem Biophys Res Commun; 2017 Jan; 483(1):82-87. PubMed ID: 28057484
[TBL] [Abstract][Full Text] [Related]
13. RhoA Kinase (Rock) and p90 Ribosomal S6 Kinase (p90Rsk) phosphorylation of the sodium hydrogen exchanger (NHE1) is required for lysophosphatidic acid-induced transport, cytoskeletal organization and migration.
Wallert MA; Hammes D; Nguyen T; Kiefer L; Berthelsen N; Kern A; Anderson-Tiege K; Shabb JB; Muhonen WW; Grove BD; Provost JJ
Cell Signal; 2015 Mar; 27(3):498-509. PubMed ID: 25578862
[TBL] [Abstract][Full Text] [Related]
14. PI3K/Akt-dependent phosphorylation of GSK3β and activation of RhoA regulate Wnt5a-induced gastric cancer cell migration.
Liu J; Zhang Y; Xu R; Du J; Hu Z; Yang L; Chen Y; Zhu Y; Gu L
Cell Signal; 2013 Feb; 25(2):447-56. PubMed ID: 23123500
[TBL] [Abstract][Full Text] [Related]
15. RhoA and lysophosphatidic acid are involved in the actin cytoskeleton reorganization of astrocytes exposed to ethanol.
Guasch RM; Tomas M; Miñambres R; Valles S; Renau-Piqueras J; Guerri C
J Neurosci Res; 2003 May; 72(4):487-502. PubMed ID: 12704810
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation and Activation of RhoA by ERK in Response to Epidermal Growth Factor Stimulation.
Tong J; Li L; Ballermann B; Wang Z
PLoS One; 2016; 11(1):e0147103. PubMed ID: 26816343
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-phosphate initiates rapid retraction of pseudopodia by localized RhoA activation.
Koh E; Clair T; Hermansen R; Bandle RW; Schiffmann E; Roberts DD; Stracke ML
Cell Signal; 2007 Jun; 19(6):1328-38. PubMed ID: 17307336
[TBL] [Abstract][Full Text] [Related]
18. Type II cGMP‑dependent protein kinase inhibits the migration, invasion and proliferation of several types of human cancer cells.
Wu M; Wu Y; Qian H; Tao Y; Pang J; Wang Y; Chen Y
Mol Med Rep; 2017 Oct; 16(4):5729-5737. PubMed ID: 28849123
[TBL] [Abstract][Full Text] [Related]
19. Cyclic Guanosine Monophosphate (cGMP)-Dependent Protein Kinase II Blocks Epidermal Growth Factor (EGF)/Epidermal Growth Factor Receptor (EGFR)-Induced Biological Effects on Osteosarcoma Cells.
Li D; Hua Y; Jiang L; Huang Y; Yue J; Wu Y; Chen Y
Med Sci Monit; 2018 Apr; 24():1997-2002. PubMed ID: 29617357
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidic acid induces a migratory phenotype through a crosstalk between RhoA-Rock and Src-FAK signalling in colon cancer cells.
Leve F; Marcondes TG; Bastos LG; Rabello SV; Tanaka MN; Morgado-Díaz JA
Eur J Pharmacol; 2011 Dec; 671(1-3):7-17. PubMed ID: 21968138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]